A Verdade Sobre a Retatrutida do Paraguai (E o Evento com Renato Cariani

📌 If you spend money on supplements, you need to see this. I created a complete course with 100+ studies so you know EXACTLY what works and what's a waste of money. 👉 Access it here: https://carlosseraphim.hotmart.host/s... ⚠ Launch price — will go up soon. 💙 Did you like the content? Support the channel: 👉 Become a member:    / @endocrinoetalks   👉 Or contribute through Apoia.se: https://apoia.se/endocrinoetalks Retratrutide from Paraguay: the illegal “launch”, Etikus, Cariani and the path to thinness In this investigative video, endocrinologist Dr. Carlos Eduardo Seraphim analyzes the controversy surrounding the alleged launch of a weight-loss pen in Paraguay that claims to contain retratrutide — a molecule still under development by the pharmaceutical company Eli Lilly and which has not been approved by any regulatory agency in the world to date (neither FDA, nor Anvisa, nor Dinavisa). This episode explores the event promoted by the Paraguayan pharmaceutical company Etikus, where the product Redofest 12 was presented, and discusses the participation of Brazilian fitness influencers in the event, including Renato Cariani. In addition, the video investigates: Who is behind the Scavone Group, one of the most powerful pharmaceutical conglomerates in Paraguay? The controversies and accusations involving this business empire. What retratrutide really is — an experimental drug that acts as a triple agonist (GLP-1, GIP, and glucagon). The preliminary data from the TRIUMPH-4 study, which showed an average loss of 28.7% of body weight in 68 weeks, an unprecedented result in obesity pharmacology. But there is a central problem: retratrutide is still in the clinical trial phase. This means that any product sold today claiming to contain this substance is illegal and potentially dangerous. The video also discusses the complexity of manufacturing this type of peptide, which requires sophisticated industrial processes and billions of dollars in investment, raising doubts about the actual production capacity of other laboratories at this time. Another point investigated is the so-called "slimming route," a smuggling scheme involving slimming pens that enter Brazil through the border with Paraguay. According to estimates, this illegal market may generate around R$ 600 million per year, with frequent seizures by the Federal Highway Police. Among the problems identified by the authorities are: Products without active ingredient Pens with substances different from the label Inconsistent dosages Transportation without a refrigeration chain, essential for peptide medications The video also analyzes the official statement from Dinavisa, the Paraguayan regulatory agency, which stated that the product does not have sanitary registration or authorization for manufacture, import, promotion, or sale in the country. Given this, the recommendation from the authorities is clear: do not consume this type of product and report illegal advertisements or sales. This episode discusses science, the pharmaceutical market, digital influence, and the risks of unapproved medications. Chapters 00:00 The illegal pen in Paraguay 01:16 Who is the pharmaceutical company Eticos? 03:04 What is retratrudate? 04:59 Can retratrudate be manufactured outside of Lilly? 07:24 The "skinny route" in Brazil 08:04 Seizures, counterfeits, and the illegal market 09:19 Evidence-based supplementation course 09:58 The event in Paraguay and Cariani's presence 11:49 Dinavisa's statement 13:58 The risks and the final message ⚠️ LEGAL NOTICE: This video is for educational and informational purposes only. Always consult a qualified healthcare professional before starting any supplementation.